Novel compounds

Details for Australian Patent Application No. 2009324811 (hide)

Owner GlaxoSmithKline LLC

Inventors Esken, Holly; Norton, Beth Adams

Agent Davies Collison Cave

Pub. Number AU-A-2009324811

PCT Pub. Number WO2010/068581

Priority 61/120,596 08.12.08 US

Filing date 7 December 2009

Wipo publication date 17 June 2010

International Classifications

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/068581 Priority application(s): WO2010/068581

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009324813-A valve assembly having a unitary valve sleeve

2009324810-Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1